Ohio

Needleless COVID vaccine trials begin with the help of “special” participants and dogs

Research is underway on new needleless vaccines that scientists believe may be superior to injectable vaccines. Cincinnati Children’s Hospital is enrolled in the exam. “This is an experimental COVID vaccine test with nasal administration,” he said. Dr. Paul Spearman, Children’s Hospital. In many cases, the absence of a needle gives an advantage over all other COVID-19 vaccines, but researchers say there are other reasons as well. Sites that viruses can attack. It can prevent the first infection. It can also prevent the spread of the virus, “Spearman said. Children are one of three sites nationwide studying the nasal COVID-19 vaccine. The exam requires certain types of participants. This study enrolls adults who are not infected with COVID-19 and have not been vaccinated. “This is a challenge,” said Spearman. “It’s a group of special people we’re really looking for.” Researchers have just started registering. So far, 11 adults have been enrolled, but we hope to get about 80. The new vaccine uses a live virus like other nasal vaccines for influenza. It has a vector that wasn’t previously used by humans, but scientists believe it’s safe because people have come into contact with it through pets. “Pi5 virus itself, parainfluenza virus type 5 is part of the kennel cough vaccine given to dogs, and people are exposed to it. Participants receive an incentive of $ 975.00, which is a needleless vaccine. However, those participating in the study will need to collect blood with a needle. Click here to register redcap.link/COVID-19Vaccine

Research is underway on new needleless vaccines that scientists believe may be superior to injected vaccines.

Cincinnati Children’s Hospital is enrolled in the exam.

“This is an experimental COVID vaccine trial with nasal administration,” said Dr. Paul Spearman, a children’s hospital.

For many, the absence of a needle is sufficient to be advantageous over all other COVID-19 vaccines, but researchers say there are other reasons.

“It has the potential advantage of mucosal immunity, which means that you are in a place where the virus can attack. It can prevent the initial infection. It can also prevent the spread of the virus.” Spearman said.

Childrens is one of three sites nationwide researching nasal COVID-19 vaccines.

The trial is seeking certain types of participants. This study enrolled adults who were not infected with COVID-19 and were not vaccinated.

“It’s a challenge,” Spearman said. “It’s a group of special people we’re really looking for.”

Researchers have just started registration. So far, they have registered 11 adults, but they want to get about 80.

The new vaccine uses the live virus like any other nasal vaccine for influenza.

It has a vector that has never been used by humans, but scientists believe it is safe because people have come into contact with it through pets.

“Pi5 virus itself, parainfluenza virus type 5, is part of the kennel cough vaccine given to dogs and people are exposed to it. Because it is being evaluated, we do so. I know they are, and as far as we know, they never had any symptoms, “Spearman said.

Participants will be given an incentive of $ 975.00, which is a needle-free vaccine, but those participating in the study will need to draw blood with a needle.

Click here to register redcap.link/COVID-19Vaccine

Needleless COVID vaccine trials begin with the help of “special” participants and dogs

Source link Needleless COVID vaccine trials begin with the help of “special” participants and dogs

Related Articles

Back to top button